Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
New patch aims to fix knee cartilage – but study halted early
Disease control TerminatedThis study tested a special collagen membrane (Chondro-Gide®) to help repair damaged knee cartilage in 75 people aged 18-55. The goal was to see if the membrane safely improves cartilage healing, measured by MRI scans and knee function scores. The trial was terminated early, so r…
Phase: NA • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Knee cartilage patch study halted early
Disease control TerminatedThis study tested whether a special collagen patch (Chondro-Gide) placed over large knee cartilage injuries could help people recover as well as standard microfracture surgery for smaller injuries. The study planned to enroll 82 people aged 18-55 with knee cartilage damage. Howev…
Phase: NA • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC